文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

改善临床试验方案中的患者报告结局部分:教育研讨会的混合方法评估。

Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.

机构信息

Sydney Quality of Life Office, School of Psychology, University of Sydney, Sydney, NSW, 2006, Australia.

Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

出版信息

Qual Life Res. 2022 Oct;31(10):2901-2916. doi: 10.1007/s11136-022-03127-w. Epub 2022 May 12.


DOI:10.1007/s11136-022-03127-w
PMID:35553325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9470723/
Abstract

INTRODUCTION: Failure to incorporate key patient-reported outcome (PRO) content in trial protocols affects the quality and interpretability of the collected data, contributing to research waste. Our group developed evidence-based training specifically addressing PRO components of protocols. We aimed to assess whether 2-day educational workshops improved the PRO completeness of protocols against consensus-based minimum standards provided in the SPIRIT-PRO Extension in 2018. METHOD: Annual workshops were conducted 2011-2017. Participants were investigators/trialists from cancer clinical trials groups. Although developed before 2018, workshops covered 15/16 SPIRIT-PRO items. Participant feedback immediately post-workshop and, retrospectively, in November 2017 was summarised descriptively. Protocols were evaluated against SPIRIT-PRO by two independent raters for workshop protocols (developed post-workshop by participants) and control protocols (contemporaneous non-workshop protocols). SPIRIT-PRO items were assessed for completeness (0 = not addressed, 10 = fully addressed). Mann-Whitney U tests assessed whether workshop protocols scored higher than controls by item and overall. RESULTS: Participants (n = 107) evaluated the workshop positively. In 2017, 16/41 survey responders (39%) reported never applying in practice; barriers included role restrictions (14/41, 34%) and lack of time (5/41, 12%). SPIRIT-PRO overall scores did not differ between workshop (n = 13, median = 3.81/10, interquartile range = 3.24) and control protocols (n = 9, 3.51/10 (2.14)), (p = 0.35). Workshop protocols scored higher than controls on two items: 'specify PRO concepts/domains' (p = 0.05); 'methods for handling missing data' (p = 0.044). CONCLUSION: Although participants were highly satisfied with these workshops, the completeness of PRO protocol content generally did not improve. Additional knowledge translation efforts are needed to assist protocol writers address SPIRIT-PRO guidance and avoid research waste that may eventuate from sub-optimal PRO protocol content.

摘要

简介:未能在试验方案中纳入关键的患者报告结局(PRO)内容会影响所收集数据的质量和可解释性,导致研究浪费。我们的团队专门开发了基于证据的培训,专门针对方案中的 PRO 内容。我们旨在评估为期两天的教育研讨会是否能够提高方案的 PRO 完整性,以符合 2018 年 SPIRIT-PRO 扩展版中提出的基于共识的最低标准。

方法:年度研讨会于 2011-2017 年举行。参与者为癌症临床试验组的研究者/试验人员。尽管这些研讨会是在 2018 年之前开发的,但它们涵盖了 15/16 项 SPIRIT-PRO 内容。参与者在研讨会结束后立即和 2017 年 11 月进行了回顾性反馈,反馈内容进行了描述性总结。两名独立评估者根据 SPIRIT-PRO 对研讨会方案(由参与者在研讨会后制定)和对照组方案(同期非研讨会方案)进行评估。SPIRIT-PRO 项目的完整性评估(0=未解决,10=完全解决)。曼-惠特尼 U 检验评估了项目和总体上,研讨会方案是否比对照组得分更高。

结果:107 名参与者对研讨会给予了积极评价。在 2017 年,16/41 名调查回应者(39%)表示从未在实践中应用过;障碍包括角色限制(14/41,34%)和缺乏时间(5/41,12%)。研讨会方案的 SPIRIT-PRO 总体评分与对照组方案(n=9,中位数为 3.81/10,四分位距为 3.24)没有差异(p=0.35)。在“指定 PRO 概念/领域”(p=0.05)和“处理缺失数据的方法”(p=0.044)两个项目上,研讨会方案的评分高于对照组。

结论:尽管参与者对这些研讨会非常满意,但 PRO 方案内容的完整性通常没有提高。需要进一步进行知识转化工作,以帮助方案撰写者遵循 SPIRIT-PRO 指南,避免因 PRO 方案内容不理想而导致的研究浪费。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3361/9470723/20016eb6be2d/11136_2022_3127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3361/9470723/20016eb6be2d/11136_2022_3127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3361/9470723/20016eb6be2d/11136_2022_3127_Fig1_HTML.jpg

相似文献

[1]
Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.

Qual Life Res. 2022-10

[2]
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

JAMA. 2018-2-6

[3]
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.

BMJ Open. 2021-6-30

[4]
Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.

PLoS One. 2014-10-15

[5]
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines.

JAMA. 2022-5-17

[6]
The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols.

Qual Life Res. 2016-10

[7]
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.

BMJ. 2020-9-9

[8]
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.

Nat Med. 2020-9-9

[9]
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.

Lancet Digit Health. 2020-10

[10]
Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.

J Patient Rep Outcomes. 2022-12-22

本文引用的文献

[1]
International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study.

Cancer Med. 2021-8

[2]
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.

BMJ Open. 2021-6-30

[3]
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Lancet Oncol. 2020-2

[4]
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.

Crit Rev Oncol Hematol. 2020-1-18

[5]
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.

Lung Cancer. 2020-1

[6]
Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.

J Natl Cancer Inst. 2019-11-1

[7]
The importance of patient-reported outcomes in clinical trials and strategies for future optimization.

Patient Relat Outcome Meas. 2018-11-1

[8]
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.

Ann Oncol. 2018-12-1

[9]
Confidence intervals of the Mann-Whitney parameter that are compatible with the Wilcoxon-Mann-Whitney test.

Stat Med. 2018-7-8

[10]
Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).

Qual Life Res. 2018-6-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索